Bazemore Robert B
- SEC CIK
- 0001620152
No open-market purchases or sales filed in the past year.
Current role at each company
- ARDX Ardelyx, Inc.Directoras of Jun 18, 2026
- NUVB Nuvation Bio Inc.Directoras of May 26, 2026
- AKTX Akari Therapeutics PlcDirectoras of Dec 18, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bazemore Robert B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKTX Akari Therapeutics Plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)9:56 PM ET | Dec 16 | 2 days | Bazemore Robert BDirector | PPurchaseAmerican Depositary Shares representing Ordinary Shares | +309.3K | $0.4041 | +$62.5K | –30.9K after | Derivative4 lots |